ProSavin® a gene therapy approach for the treatment of Parkinson's Disease: a Phase I Clinical Trial Update

被引：0

作者：

Palfi, Stephane ^{[1
,3
]}

Watts, Collin ^{[4
]}

Marc, Gurruchaga Jean ^{[3
]}

Peter, Buttery ^{[4
]}

Scott, Ralph ^{[2
]}

Sarah, Deeley ^{[2
]}

Helene, Lepetit ^{[3
]}

James, Miskin ^{[2
]}

Hiro, Iwamuro ^{[3
]}

Sonia, Lavisse ^{[1
]}

Aurelie, Kas ^{[1
]}

Laure, Ramelli Anne ^{[3
]}

Naoki, Tani ^{[3
]}

Gilles, Fenelon ^{[3
]}

Pierre, Brugie're ^{[3
]}

Stuart, Naylor ^{[2
]}

Philippe, Hantraye ^{[1
]}

Philippe, Remy ^{[1
,3
]}

Roger, Barker ^{[4
]}

Kyriacos, Mitrophanous ^{[2
]}

机构：

[1] CEA I2BM MirCen, Fontenay Aux Roses, France

[2] Oxford Biomed Ltd, Oxford, England

[3] Hop Henri Mondor, APHP, F-94010 Creteil, France

[4] Cambridge Ctr Brain Repair, Cambridge, England

来源：

HUMAN GENE THERAPY | 2012年 / 23卷 / 10期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：A61 / A61

页数：1

共 50 条

[1] ProSavin® a Gene Therapy Approach for the Treatment of Parkinson's Disease: Phase I Clinical Trial Update
Palfi, S.
Gurruchaga, J-M
Scorer, S.
Ralph, S.
Lepetit, H.
Jarraya, B.
Miskin, J.
Iwamuro, H.
Lavisse, S.
Ramelli, A. L.
Tani, N.
Dolphin, P.
Abhay, K.
Gabriel, I.
Fenelon, G.
Brugiere, P.
Kingsman, S.
Price, G.
Naylor, S.
Hantraye, P.
Remy, P.
Mitrophanous, K.
HUMAN GENE THERAPY, 2011, 22 (10) : A20 - A20
[2] ProSavin® a Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial Update
Palfi, Stephane
Watts, Colin
Gurrachaga, Jean-Marc
Buttery, Philip
Ralph, Scott
Deeley, Saray
Lepetit, Helene
Miskin, James
Iwamuro, Hirokazu
Lavisse, Sonia
Kas, Aurelie
Ramelli, Anne Laure
Tani, Naoki
Dolphin, Patrice
Abhay, K.
Gabriel, I.
Fenelon, Gilles
Brugiere, Pierre
Naylor, Stuart
Hantraye, Philippe
Remy, Philippe
Barker, Roger
Mitrophanous, Kyriacos
MOLECULAR THERAPY, 2012, 20 : S23 - S23
[3] ProSavin® a Gene Therapy Approach for Parkinson Disease: Phase I Clinical Trial Update
Palfi, S.
Jarraya, B.
Gurruchaga, J-M
Ralph, S.
Lepetit, H.
Lavisse, S.
Miskin, J.
Kas, A.
Fenelon, S.
Brugiere, P.
Kingsman, S.
Naylor, S.
Hantraye, P.
Remy, K.
Mitrophanous, K.
HUMAN GENE THERAPY, 2010, 21 (10) : 1364 - 1364
[4] ProSavin® a Dopamine Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial
Palfi, S.
Gurruchaga, J. -M.
Ralph, G. S.
Watts, C.
Buttery, P.
Scorer, S.
Lepetit, H.
Miskin, J.
Iwamuro, H.
Lavisse, S.
Kas, A.
Ramelli, A. L.
Tani, N.
Dolphin, P.
Fenelon, G.
Brugiere, P.
Kingsman, S.
Naylor, S.
Hantraye, P.
Remy, P.
Barker, R.
Mitrophanous, K.
CELL TRANSPLANTATION, 2013, 22 (05) : 911 - 911
[5] A phase I/II clinical trial to evaluate the safety and efficacy of ProSavin®, a gene therapy approach for Parkinson's disease
Jarraya, B.
Lepetit, H.
Ralph, S.
Boulet, S.
Jan, C.
Bonvento, G.
Miskin, J.
Gurruchaga, J. -M.
Vinti, M.
Fenelon, G.
Brugiere, P.
Kingsman, S.
Hantraye, P.
Remy, P.
Mitrophanous, K.
Palfi, S.
PARKINSONISM & RELATED DISORDERS, 2009, 15 : S145 - S145
[6] ProSavin a gene therapy approach for Parkinson's disease
Jarraya, Bechir
Lepitit, Helene
Ralph, Scott
Tani, Naoki
Boulet, Sabrina
Jan, Caroline
Bonvento, Gilles
Miskin, James
Gurruchaga, Jean-Marc
Vinti, Maria
Fenelon, Gilles
Brugiere, Pierre
Kingsman, Susan
Hantraye, Philippe
Remy, Philippe
Mitrophanous, Kyriacos
Palfi, Stephane
HUMAN GENE THERAPY, 2009, 20 (11) : 1391 - 1392
[7] Prosavin®, a dopamine gene therapy for advanced Parkinson's disease: 5 years phase I/II clinical update
Palfi, S.
Gurruchaga, J. M.
Watts, C.
Buttery, P. C.
Lepetit, H.
Fenelon, G.
Binley, K.
Howard, K.
Lad, Y.
Tuckwell, N. J.
Hantraye, P.
Barker, R. A.
Mitrophanous, K. A.
HUMAN GENE THERAPY, 2018, 29 (12) : A87 - A87
[8] A phase I clinical trial on the safety and efficacy of ProSavin® a dopamine replacement gene therapy for Parkinson's disease (PD): An interim report
Jarraya, B.
Lepetit, H.
Ralph, S.
Miskin, J.
Gurruchaga, J. -M.
Vinti, M.
Fenelon, G.
Brugieres, P.
Abhay, K.
Gabriel, I.
Boulet, S.
Jan, C.
Kingsman, S.
Cesaro, P.
Hantraye, P.
Remy, P.
Mitrophanous, K.
Palfi, S.
MOVEMENT DISORDERS, 2010, 25 (07) : S267 - S267
[9] ProSavin: A gene therapy for Parkinson's Disease
Jarraya, Bechir
Ralph, Scott
Lepetit, Helene
Boulet, Sabrina
Jan, Caroline
Bonvento, Gilles
Azzouz, Mimoun
Miskin, James
Gurruchaga, Jean Marc
Palfi, Stephane
Fenelon, Gilles
Brugiere, Pierre
Day, Debbie
Kingsman, Susan
Hantraye, Philippe
Remy, Philippe
Mitrophanous, Kyriacos
Mazarakis, Nickolas
Palfi, Stephane
HUMAN GENE THERAPY, 2008, 19 (10) : 1060 - 1061
[10] Prosavin, a dopamine gene therapy for advanced PD: phase I clinical update
Palfi, S.
Gurruchaga, J-M.
Ralph, G. S.
Watts, C.
Buttery, P.
Scorer, S.
Lepetit, H.
Miskin, J.
Iwamuro, H.
Lavisse, S.
Kas, A.
Ramelli, A. L.
Tani, N.
Dolphin, P.
Fenelon, G.
Brugiere, P.
Kingsman, S.
Naylor, S.
Barker, R.
Hantraye, P.
Remy, P.
Cesaro, P.
Mitrophanous, K.
NEUROREPORT, 2014, 25 (03) : 147 - 147

← 1 2 3 4 5 →